CAMP4 Therapeutics Stock (NASDAQ:CAMP)
Previous Close
$3.11
52W Range
$1.30 - $12.26
50D Avg
$2.38
200D Avg
$2.90
Market Cap
$59.07M
Avg Vol (3M)
$796.51K
Beta
1.02
Div Yield
-
CAMP Company Profile
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.